Clinical SuccessA post-hoc analysis showed that the use of DrugSorb-ATR resulted in a significant reduction in severe bleeding complications in patients who underwent coronary artery bypass graft surgery.
Market RecoveryThe quarter saw significant recovery in the Central European markets especially as post-COVID headwinds dissipate.
New Product LaunchThe company plans to launch PuriFi, a novel hemoperfusion pump, in select international markets where hemodialysis infrastructure is lacking.